KRAS and neoplasm: We, therefore, tested the antigen specificity of PDAC-infiltrating B cells (TIB) by first isolating them from tumor tissue, immortalizing them using Epstein-Barr virus (EBV) infection and assessing their IgG production against wild type and mutant KRAS targets.